[ad_1]
FInland announced Thursday that it will suspend distribution of the Moderna COVID-19 vaccine to younger men, saying the low risk of heart inflammation exceeds the risk of contracting COVID-19 for this demographic.
The study, which found that men under the age of 30 had “a slightly higher risk than others of developing myocarditis” after receiving the Moderna vaccine, is expected to be published in a few weeks. Mika Salminen, director of the Finnish Institute of Health, said Finland would meanwhile administer the Pfizer vaccine to younger men, according to Reuters.
WHAT DELAYED THE COVID-19 LIFE ANTIVIRAL PILL?
Moderna said incidents “are generally mild cases and individuals tend to recover quickly after standard treatment and rest.”
“The risk of myocarditis is greatly increased for those who contract COVID-19, and vaccination is the best way to protect against it,” the company added.
Swedish and Danish health officials announced on Wednesday that they would suspend the use of the Moderna vaccine for all young adults and children, citing the same unpublished study as Finland, the report added.
Myocarditis is inflammation of the heart muscle, with symptoms such as chest pain, shortness of breath, and a feeling of having an abnormal heart beat. Inflammation usually occurs a few days after the second injection of the COVID-19 vaccine. Despite this possibility, experts at the Centers for Disease Control and Prevention say the benefits of getting vaccinated against COVID-19 outweigh the risks.
CLICK HERE TO LEARN MORE ABOUT THE WASHINGTON EXAMINER
Finland reported 666 new cases of the disease in the past 24 hours on Thursday. More than 4.1 million people received their first dose of the COVID-19 vaccine in the country, with more than 3,520,691 residents fully vaccinated on Monday, the World Health Organization reported.
Representatives for Moderna did not immediately respond to the Washington Examiner’s request for comment.
Washington Examiner Videos
Key words: News, Finland, Vaccination, Coronavirus, men
Original author: Asher notheis
Original location: Finland suspends Moderna COVID-19 vaccines for men 30 and under due to risk of heart inflammation
[ad_2]
Source link